52.77 F
Rexburg
June 25, 2021
Uncategorized

First case of rare blood-clotting condition linked to J&J COVID-19 vaccine diagnosed in Utah

SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah.

A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release.

The patient was treated and is now recovering at home, according to the release. Health officials didn’t provide any more detail about the case in the release. A news conference is scheduled for 2:30 p.m. Wednesday where doctors are expected to further discuss the case.

The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after six cases were reported among over 6 million people who received the vaccine. The pause was lifted on April 23 after federal regulators determined the vaccine’s continued use was safe.

This story will be updated.

More stories you may be interested in

Related posts

Bruins overwhelm Utes, roll to 76-61 victory at the Huntsman Center

N L

Utah County elects first female county commissioner

N L

Wildfire updates: 2,000-acre fire in Washington County 75% contained

N L

Granite School District selects new superintendent

N L

With 6-0 start, BYU inches up to No. 10 in Coaches Poll, No. 11 in AP Top 25

N L

Whether ‘Zach’s Fifth Avenue’ or ‘Wall Street Wilson,’ former BYU QB takes confident game to Big Apple

N L